3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid Cancer, Papillary
1
Polycystic Ovary Syndrome
1
Infertility
1
Head and Neck Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Iodine-131
5
lenvatinib
3
X-Rays
3
Thyrotropin Alfa
3
Magnetic Resonance Spectroscopy
3
trametinib
2
dabrafenib
2
Sunitinib
2
Specimen Handling
2
Interviews as Topic
2
vandetanib
1
tremelimumab
1
spartalizumab
1
selpercatinib
1
pembrolizumab
1
pazopanib
1
durvalumab
1
cobimetinib
1
cabozantinib
1
Vemurafenib
1
Thyrotropin
1
Thalidomide
1
Surgical Procedures, Operative
1
Sorafenib
1
Sodium Iodide
1
Semaxinib
1
Photons
1
Photochemotherapy
1
Phantoms, Imaging
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma, Follicular
×
Thyrotropin
×
Clear all
NCT00415233
2023-12-19
HiLo
University College, London
Phase 3
Unknown
438 enrolled